Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ECTRIMS/EAN consensus on vaccination in people with multiple sclerosis: Improving immunization strategies in the era of highly active immunotherapeutic drugs
Susana Otero‐Romero, Christine Lebrun‐Frénay, Saúl Reyes, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 8, pp. 904-925
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Urgent Issues in Multiple Sclerosis
Methma Udawatta, Marcelo Matiello
Medical Clinics of North America (2025)
Closed Access
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MS
René Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Neurology (2025) Vol. 104, Iss. 3
Closed Access
Is it time to consider the live attenuated varicella-zoster virus (VZV) vaccination safe in patients with multiple sclerosis treated with natalizumab? An extension study of the first Iranian experience
Sepideh Paybast, Mohammad Ali Nahayati, Samira Mohammadi, et al.
Multiple Sclerosis and Related Disorders (2025) Vol. 95, pp. 106285-106285
Closed Access
Infection prevention in the immunocompromised traveler due to conditions other than transplantation: a review
Joseph Sassine, Emily A Siegrist, Rita Wilson Dib, et al.
Therapeutic Advances in Infectious Disease (2025) Vol. 12
Open Access
Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis
Simone Lorenzut, Ilaria Del Negro, Giada Pauletto, et al.
Journal of Integrative Neuroscience (2025) Vol. 24, Iss. 1
Open Access
Vaccination coverage and its determinants in patients with multiple sclerosis—a multicenter cross-sectional study
Paula Schade, Hai-Anh Nguyen, Julia Steinle, et al.
Therapeutic Advances in Neurological Disorders (2025) Vol. 18
Open Access
Vaccination in multiple sclerosis: Tackling challenges and paving the way for effective immunization
René Carvajal, Carmen Tur, Blanca Borrás-Bermejo, et al.
Multiple Sclerosis Journal (2025)
Closed Access
Vaccine Safety and Immunogenicity in Patients With Multiple Sclerosis Treated With Natalizumab
René Carvajal, Ana Zabalza, Pere Carbonell‐Mirabent, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246345-e246345
Open Access | Times Cited: 3
Vaccination status and self-reported side effects after SARS-CoV-2 vaccination in relation to psychological and clinical variables in patients with multiple sclerosis
Katja Burian, Felicita Heidler, Niklas Frahm, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
A single-dose strategy for immunization with live attenuated vaccines is an effective option before treatment initiation in multiple sclerosis patients
René Carvajal, Carmen Tur, Xavier Martínez‐Gómez, et al.
Multiple Sclerosis Journal (2023) Vol. 29, Iss. 14, pp. 1841-1848
Open Access | Times Cited: 6
Infektionen und Multiple Sklerose
Felicita Heidler, Tobias Bopp, Matthias Schwab, et al.
Fortschritte der Neurologie · Psychiatrie (2024)
Closed Access | Times Cited: 1
New consensus guidelines on vaccination in multiple sclerosis
Uwe K. Zettl, Paulus Rommer
Nature Reviews Neurology (2023) Vol. 19, Iss. 9, pp. 509-510
Closed Access | Times Cited: 4
Treatment of older patients with multiple sclerosis: Results of an International Delphi Survey
Hayrettin Tumani, Patricia K. Coyle, Claudia Cárcamo, et al.
Multiple Sclerosis Journal - Experimental Translational and Clinical (2023) Vol. 9, Iss. 3
Open Access | Times Cited: 4
Disease-modifying therapy initiation patterns in multiple sclerosis in three large MS populations
Alexander Stahmann, Elaine Craig, David Ellenberger, et al.
Therapeutic Advances in Neurological Disorders (2024) Vol. 17
Open Access
Ofatumumab in clinical practice
Martin Elišák
Neurologie pro praxi (2024) Vol. 25, Iss. 1, pp. 62-65
Closed Access
Disease Modifying Treatment Guidelines for Multiple Sclerosis in the United Arab Emirates
Anu Jacob, Ahmed Shatila, Jihad Inshasi, et al.
Multiple Sclerosis and Related Disorders (2024) Vol. 88, pp. 105703-105703
Closed Access
Multiple sclerosis treatment review for primary care providers
Jeffrey Hernandez
The Nurse Practitioner (2024) Vol. 49, Iss. 7, pp. 38-47
Open Access
Emerging trends and challenges in multiple sclerosis in Europe: rethinking classification and addressing COVID-19 impact
Catharina Korsukewitz, Heinz Wiendl
The Lancet Regional Health - Europe (2024) Vol. 44, pp. 101017-101017
Open Access
Challenges in Diagnosis of COVID-19 Pneumonia under Ocrelizumab and De-Risking Strategies in Multiple Sclerosis—The Elephant Is (Still) in the Room
Alice Mariottini, A Lotti, Valentina Damato, et al.
Microorganisms (2024) Vol. 12, Iss. 10, pp. 1941-1941
Open Access
Patient-centered pregnancy planning in multiple sclerosis: evidence for a new era
Elisa Matias Vieira de Melo, Bruno Cassis Antunes Rodrigues, Felipe Teijeiro Cabral, et al.
Arquivos de Neuro-Psiquiatria (2024) Vol. 82, Iss. 10, pp. 001-011
Open Access
Updated Clinical Recommendations for Multiple Sclerosis by Saudi Neurology Experts
Ahmed Hasan Althobaiti, Ahmad Abulaban, Reem F. Bunyan, et al.
Saudi Journal of Clinical Pharmacy (2024) Vol. 3, Iss. 3, pp. 101-116
Closed Access
Thought he would never go…
Alan J. Thompson
Multiple Sclerosis Journal (2024) Vol. 30, Iss. 14, pp. 1701-1703
Closed Access
Live-attenuated vaccines for multiple sclerosis patients living in regions with endemic infections: A complex decision
Jorge Correale, Mariano Marrodán
Multiple Sclerosis Journal (2024)
Closed Access
Optimizing Drug Selection in Children with Multiple Sclerosis: What Do We Know and What Remains Unanswered?
Rabporn Suntornlohanakul, E. Ann Yeh
Pediatric Drugs (2024)
Closed Access
XVI Reunión Post-ECTRIMS: revisión de las novedades presentadas en el Congreso ECTRIMS 2023 (II)
Óscar Fernández, Xavier Montalbán, Eduardo Agüera, et al.
Revista de Neurología (2024) Vol. 79, Iss. 02, pp. 51-51
Open Access
Page 1 - Next Page

Scroll to top